186 related articles for article (PubMed ID: 31810635)
1. Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect.
Moosavi B; Zhu XL; Yang WC; Yang GF
Eur J Cell Biol; 2020 Jan; 99(1):151057. PubMed ID: 31810635
[TBL] [Abstract][Full Text] [Related]
2. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
3. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma.
Dona M; Neijman K; Timmers HJLM
Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
5. Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.
Dwight T; Na U; Kim E; Zhu Y; Richardson AL; Robinson BG; Tucker KM; Gill AJ; Benn DE; Clifton-Bligh RJ; Winge DR
BMC Cancer; 2017 Jul; 17(1):497. PubMed ID: 28738844
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract][Full Text] [Related]
8. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract][Full Text] [Related]
9. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
Smith EH; Janknecht R; Maher LJ
Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
[TBL] [Abstract][Full Text] [Related]
10. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
Vicha A; Taieb D; Pacak K
Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.
Taïeb D; Timmers H; Pacak K
Horm Metab Res; 2019 Jul; 51(7):414-418. PubMed ID: 29618137
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
13. 15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma.
Mannelli M; Rapizzi E; Fucci R; Canu L; Ercolino T; Luconi M; Young WF
Endocr Relat Cancer; 2015 Aug; 22(4):T83-90. PubMed ID: 26113605
[TBL] [Abstract][Full Text] [Related]
14. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
Barletta JA; Hornick JL
Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytomas: from genetic diversity to new paradigms.
Qin Y; Buddavarapu K; Dahia PL
Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
[TBL] [Abstract][Full Text] [Related]
17. Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function.
Rapizzi E; Fucci R; Giannoni E; Canu L; Richter S; Cirri P; Mannelli M
Endocr Relat Cancer; 2015 Jun; 22(3):409-17. PubMed ID: 25808177
[TBL] [Abstract][Full Text] [Related]
18. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
Gupta S; Zhang J; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
[TBL] [Abstract][Full Text] [Related]
19. Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeast.
Chang YL; Hsieh MH; Chang WW; Wang HY; Lin MC; Wang CP; Lou PJ; Teng SC
Antioxid Redox Signal; 2015 Mar; 22(7):587-602. PubMed ID: 25328978
[TBL] [Abstract][Full Text] [Related]
20. Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor.
Goffrini P; Ercolino T; Panizza E; Giachè V; Cavone L; Chiarugi A; Dima V; Ferrero I; Mannelli M
Hum Mol Genet; 2009 May; 18(10):1860-8. PubMed ID: 19261679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
